These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers. Koedam JA; Hoogerbrugge CM; Van Buul-Offers SC Biochem Biophys Res Commun; 1997 Nov; 240(3):707-14. PubMed ID: 9398631 [TBL] [Abstract][Full Text] [Related]
31. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Qin X; Byun D; Lau KH; Baylink DJ; Mohan S Arch Biochem Biophys; 2000 Jul; 379(2):209-16. PubMed ID: 10898936 [TBL] [Abstract][Full Text] [Related]
32. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Le H; Arnold JT; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782 [TBL] [Abstract][Full Text] [Related]
33. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit. Twigg SM; Hardman KV; Baxter RC Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705 [TBL] [Abstract][Full Text] [Related]
34. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance. Carrick FE; Hinds MG; McNeil KA; Wallace JC; Forbes BE; Norton RS J Mol Endocrinol; 2005 Jun; 34(3):685-98. PubMed ID: 15956340 [TBL] [Abstract][Full Text] [Related]
35. Role of insulin-like growth factor binding proteins in the control of IGF actions. Clemmons DR; Busby WH; Arai T; Nam TJ; Clarke JB; Jones JI; Ankrapp DK Prog Growth Factor Res; 1995; 6(2-4):357-66. PubMed ID: 8817679 [TBL] [Abstract][Full Text] [Related]
36. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo. Ohleth KM; Lenhart JA; Ryan PL; Radecki SV; Bagnell CA Endocrinology; 1997 Sep; 138(9):3652-8. PubMed ID: 9275049 [TBL] [Abstract][Full Text] [Related]
37. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166 [TBL] [Abstract][Full Text] [Related]
38. The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis. Durham SK; Suwanichkul A; Hayes JD; Herington AC; Powell DR; Campbell PG Horm Metab Res; 1999; 31(2-3):216-25. PubMed ID: 10226805 [TBL] [Abstract][Full Text] [Related]
39. Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components. Jehle PM; Fussgaenger RD; Blum WF; Angelus NK; Hoeflich A; Wolf E; Jungwirth RJ Horm Metab Res; 1999; 31(2-3):97-102. PubMed ID: 10226788 [TBL] [Abstract][Full Text] [Related]